This latest product is bioequivalent and therapeutically equivalent to Xalatan® Ophthalmic Solution, 0.005% of Upjohn US 2 LLC. According to IQVIA sales data for the 12-month period ending ...

Purpose: We investigated the intraocular pressure (IOP) variations after switching from 0.005% latanoprost to 0.01% bimatoprost in open-angle glaucoma patients who experienced IOP elevation during ...